Allie Seaton
Physician Assistant · Medina, TNNPI 1427696582
Payments from drug & device makers
Across 609 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$1K
- UCB, Inc.$859
- Biogen$771
- AstraZeneca$610
- SK Life Science, Inc.$597
- plus $4K from 30 others
What the payments were for
- Food & beverage$10,153100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 129 | $1,851 |
| Pfizer | 101 | $1,023 |
| UCB, Inc. | 29 | $859 |
| Biogen | 42 | $771 |
| AstraZeneca(2 entities) | 27 | $610 |
| SK Life Science, Inc. | 25 | $597 |
| Novartis | 31 | $542 |
| Argenx US, Inc. | 21 | $396 |
| Lundbeck LLC | 23 | $360 |
| Bristol Myers Squibb | 20 | $353 |
| Amneal Pharmaceuticals LLC | 17 | $341 |
| Teva Pharmaceuticals USA, Inc. | 20 | $339 |
| Eisai Inc. | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. | 18 | $304 |
| Neurocrine Biosciences, Inc. | 9 | $189 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $153 |
| Amgen(2 entities) | 8 | $139 |
| Johnson & Johnson | 18 | $120 |
| Genentech USA, Inc. | 6 | $109 |
| TG Therapeutics, Inc. | 3 | $95 |
| Sanofi | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Acadia Pharmaceuticals Inc | 4 | $72 |
| Neurelis, Inc. | 3 | $61 |
| EMD Serono, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Merz Pharmaceuticals, LLC | 1 | $46 |
| Catalyst Pharmaceuticals, Inc. | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $38 |
| Avion Pharmaceuticals | 2 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| CSL Behring | 1 | $19 |
| Grifols USA, LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $8 |
How this compares
$10,153 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 85 | $136,815 |
| Nurtec OdtRimegepant Sulfate | 74 | $105,231 |
| Emgality PenGalcanezumab-Gnlm | 76 | $57,338 |
| Aimovig AutoinjectorErenumab-Aooe | 57 | $43,729 |
| EliquisApixaban | 64 | $29,358 |
| AptiomEslicarbazepine Acetate | 12 | $28,673 |
| QuliptaAtogepant | 23 | $25,654 |
| RexultiBrexpiprazole | 17 | $22,923 |
| XcopriCenobamate | 20 | $21,898 |
| Levetiracetam | 205 | $7,882 |
| Memantine Hcl | 252 | $6,441 |
| RytaryCarbidopa/Levodopa | 11 | $4,685 |
| Lacosamide | 12 | $3,417 |
| Oxcarbazepine | 46 | $3,038 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 110 | $2,608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $1,851 | $162,469108 claims |
| PfizerNurtec Odt, Eliquis, Dilantin | $1,023 | $135,074150 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $38 | $28,67312 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $304 | $22,92317 claims |
| SK Life Science, Inc.Xcopri | $597 | $21,89820 claims |
| Amneal Pharmaceuticals LLCRytary | $341 | $4,68511 claims |
| Johnson & JohnsonXarelto | $120 | $2,45117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Medina
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.